Citigroup
LKFT

Citigroup’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Citigroup’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,000
Closed -$1.04M – 6200
2025
Q3 		$1.04M Buy
+30,000
New +$960K ﹤0.01% 3138
2024
Q2 		– Sell
-30,000
Closed -$966K – 5655
2024
Q1 		$966K Hold
30,000
– – ﹤0.01% 3053
2023
Q4 		$1.22M Buy
+30,000
New +$1.1M ﹤0.01% 2659

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Citigroup's LKFT Position: Q2 2026 in Review

Citigroup reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 29% in Q2 2026, selling an estimated $4.09K and leaving 354 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5238.

Citigroup first reported a position in LKFT in Q3 2015 and has held it in 34 quarters since. The position peaked at $20.6M in Q2 2020. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Citigroup held 354 shares of Lakefront Biotherapeutics American Depositary Shares worth $10.6K as of Q2 2026.
  • Citigroup sold 144 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $4.09K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5238 holding.
  • Citigroup first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 34 quarters since.
  • Citigroup's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.6M in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.